Skip to main content
Decorative image of the COVID-19 Learning Lounge

Is It COVID or the Flu? New Combo Tests Can Find Out


Conversations surrounding COVID-19 and the use of diagnostics continue to dominate the media, bringing greater familiarity to the value that diagnostic information has in the healthcare pathway. This latest article released by the New York Times includes experts like Mark Miller, MD, chief medical officer at bioMérieux, who discusses the need of today's clinical diagnostics to simultaneously test for more pathogens like COVID-19 for optimal infectious disease management. Labs are preparing for testing demands to skyrocket when the more typical seasonal flu strains reemerge in the fall. Front-line healthcare professionals want to know, which test should I use?


Mark Miller, MD, Chief Medical Officer at bioMérieux


See how Mark Miller, MD discusses the role of PCR testing on ID management in a COVID-19 world.

Read Time: 2 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

U.S. bioMérieux Solutions

US Solutions

COVID-19 Testing Solutions for Healthcare

Because every COVID-19 patient comes with a unique profile and experiences the disease differently, patient management means asking the right questions, finding the right answers and providing appropriate care the entire length of the patient pathway.


The New York Times
May 11, 2021